WaltonCKingRRechtmanLKayeWLerayEMarrieRA, et al. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Mult Scler. 2020;26(14):1816-21.
2.
BriggsFBHillE. Estimating the prevalence of multiple sclerosis using 56.6 million electronic health records from the United States. Mult Scler. 2020;26(14):1948-52.
3.
Langer-GouldAMGonzalesEGSmithJBLiBHNelsonLM. Racial and Ethnic Disparities in Multiple Sclerosis Prevalence. Neurology. 2022;98(18):e1818-e27.
4.
RomanelliRJHuangQLacyJHashemiLWongASmithA. Multiple sclerosis in a multi-ethnic population from Northern California: a retrospective analysis, 2010-2016. BMC Neurol. 2020;20(1):163.
5.
AmezcuaLRivasEJosephSZhangJLiuL. Multiple Sclerosis Mortality by Race/Ethnicity, Age, Sex, and Time Period in the United States, 1999-2015. Neuroepidemiology. 2018;50(1-2):35-40.
6.
McKayKAJahanfarSDugganTTkachukSTremlettH. Factors associated with onset, relapses or progression in multiple sclerosis: A systematic review. Neurotoxicology. 2017;61:189-212.
7.
International Multiple Sclerosis Genetics C. Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. Science. 2019;365(6460).
8.
CreeBAReichDEKhanODe JagerPLNakashimaITakahashiT, et al. Modification of Multiple Sclerosis Phenotypes by African Ancestry at HLA. Arch Neurol. 2009;66(2):226-33.
9.
GorisAPauwelsIGustavsenMWvan SonBHilvenKBosSD, et al. Genetic variants are major determinants of CSF antibody levels in multiple sclerosis. Brain. 2015;138(Pt 3):632-43.
10.
International Multiple Sclerosis Genetics C, Multiple MSC. Locus for severity implicates CNS resilience in progression of multiple sclerosis. Nature. 2023;619(7969):323-31.
11.
IsobeNKeshavanAGourraudPAZhuAHDattaESchlaegerR, et al. Association of HLA Genetic Risk Burden With Disease Phenotypes in Multiple Sclerosis. JAMA Neurol. 2016;73(7):795-802.
12.
JokubaitisVGCampagnaMPIbrahimOStankovichJKleinovaPMatesanzF, et al. Not all roads lead to the immune system: the genetic basis of multiple sclerosis severity. Brain. 2023;146(6):2316-31.
13.
BrownleeWJTurCManoleAEshaghiAPradosFMiszkielKA, et al. HLA-DRB1*1501 influences long-term disability progression and tissue damage on MRI in relapse-onset multiple sclerosis. Mult Scler. 2023;29(3):333-42.
14.
MisickaEHuangYLoomisSSadhuNFisherEGafsonA, et al. Adaptive and Innate Immunity Are Key Drivers of Age at Onset of Multiple Sclerosis. Neurol Genet. 2024;10(3):e200159.
15.
KowalecKWrightGEBDrogemollerBIAminkengFBhavsarAPKingwellE, et al. Common variation near IRF6 is associated with IFN-beta-induced liver injury in multiple sclerosis. Nat Genet. 2018;50(8):1081-5.
16.
KosaPBarbourCVarosanecMWichmanASandfordMGreenwoodM, et al. Molecular models of multiple sclerosis severity identify heterogeneity of pathogenic mechanisms. Nat Commun. 2022;13(1):7670.
17.
GrossCCSchulte-MecklenbeckASteinbergOVWirthTLauksSBittnerS, et al. Multiple sclerosis endophenotypes identified by high-dimensional blood signatures are associated with distinct disease trajectories. Sci Transl Med. 2024;16(740):eade8560.
18.
JacobsBMSchalkLTregaskis-DanielsETankPHoqueSPeterM, et al. The relationship between ethnicity and Multiple Sclerosis characteristics in the United Kingdom: a UK MS Register study. medRxiv. 2024:2024.02.02.24301981.
19.
BriggsFBSThompsonNRConwayDS. Prognostic factors of disability in relapsing remitting multiple sclerosis. Mult Scler Relat Disord. 2019;30:9-16.
20.
PanditLMalliCSinghalBWasonJMalikOSawcerS, et al. HLA associations in South Asian multiple sclerosis. Mult Scler. 2016;22(1):19-24.
21.
QiuWJamesICarrollWMMastagliaFLKermodeAG. HLA-DR allele polymorphism and multiple sclerosis in Chinese populations: a meta-analysis. Mult Scler. 2011;17(4):382-8.
22.
WatanabeMNakamuraYSatoSNiinoMFukauraHTanakaM, et al. HLA genotype-clinical phenotype correlations in multiple sclerosis and neuromyelitis optica spectrum disorders based on Japan MS/NMOSD Biobank data. Sci Rep. 2021;11(1):607.
23.
ChiCShaoXRheadBGonzalesESmithJBXiangAH, et al. Admixture mapping reveals evidence of differential multiple sclerosis risk by genetic ancestry. PLoS Genet. 2019;15(1):e1007808.
24.
BeechamAHAmezcuaLChineaAManriqueCPGomezLMartinezA, et al. Ancestral risk modification for multiple sclerosis susceptibility detected across the Major Histocompatibility Complex in a multi-ethnic population. PLoS One. 2022;17(12):e0279132.
25.
ZhouYZhuGCharlesworthJCSimpsonSJr.RubiczRGoringHH, et al. Genetic loci for Epstein-Barr virus nuclear antigen-1 are associated with risk of multiple sclerosis. Mult Scler. 2016;22(13):1655-64.
26.
IsobeNMadireddyLKhankhanianPMatsushitaTCaillierSJMoreJM, et al. An ImmunoChip study of multiple sclerosis risk in African Americans. Brain. 2015;138(Pt 6):1518-30.
27.
PanditLBanMBeechamAHMcCauleyJLSawcerSD'CunhaA, et al. European multiple sclerosis risk variants in the south Asian population. Mult Scler. 2016;22(12):1536-40.
28.
BeechamAHAmezcuaLChineaAManriqueCPRubiCIsobeN, et al. The genetic diversity of multiple sclerosis risk among Hispanic and African American populations living in the United States. Mult Scler. 2020;26(11):1329-39.
29.
BriggsFBAcunaBShenLRamsayPQuachHBernsteinA, et al. Smoking and risk of multiple sclerosis: evidence of modification by NAT1 variants. Epidemiology. 2014;25(4):605-14.
30.
BriggsFB. Nicotinic acetylcholine receptors alpha7 and alpha9 modifies tobacco smoke risk for multiple sclerosis. Mult Scler. 2021;27(8):1166-74.
31.
WangJJelcicIMuhlenbruchLHaunerdingerVToussaintNCZhaoY, et al. HLA-DR15 Molecules Jointly Shape an Autoreactive T Cell Repertoire in Multiple Sclerosis. Cell. 2020;183(5):1264-81 e20.
32.
JelcicIAl NimerFWangJLentschVPlanasRJelcicI, et al. Memory B Cells Activate Brain-Homing, Autoreactive CD4(+) T Cells in Multiple Sclerosis. Cell. 2018;175(1):85-100 e23.
33.
NakatsukaNPattersonNPatsopoulosNAAltemoseNTandonABeechamAH, et al. Two genetic variants explain the association of European ancestry with multiple sclerosis risk in African-Americans. Sci Rep. 2020;10(1):16902.
34.
du AlborCSautoyTKali VananNTurnerBPBoomlaKSchmiererK. Ethnicity and prevalence of multiple sclerosis in east London. Mult Scler. 2017;23(1):36-42.
35.
Irving-PeaseEKRefoyo-MartinezABarrieWIngasonAPearsonAFischerA, et al. The selection landscape and genetic legacy of ancient Eurasians. Nature. 2024;625(7994):312-20.
36.
BarrieWYangYIrving-PeaseEKAttfieldKEScorranoGJensenLT, et al. Elevated genetic risk for multiple sclerosis emerged in steppe pastoralist populations. Nature. 2024;625(7994):321-8.
37.
GoodinDSOksenbergJRDouillardVGourraudPAVinceN. Genetic susceptibility to multiple sclerosis in African Americans. PLoS One. 2021;16(8):e0254945.
38.
MooneyJAAgranat-TamirLPritchardJKRosenbergNA. On the number of genealogical ancestors tracing to the source groups of an admixed population. Genetics. 2023;224(3).
39.
Gray-RoncalKFitzgeraldKCRyersonLZCharvetLCassardSDNaismithR, et al. Association of Disease Severity and Socioeconomic Status in Black and White Americans With Multiple Sclerosis. Neurology. 2021;97(9):e881-e9.
40.
MisickaEDavisMFKimWBruggerSWBealesJLoomisS, et al. A higher burden of multiple sclerosis genetic risk confers an earlier onset. Mult Scler. 2022;28(8):1189-97.
41.
AmezcuaLBeechamAHDelgadoSRChineaABurnettMManriqueCP, et al. Native ancestry is associated with optic neuritis and age of onset in hispanics with multiple sclerosis. Ann Clin Transl Neurol. 2018;5(11):1362-71.
